Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Bristol Myers Squibb Co. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$63.43+1.8%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed October 29, 2026
Bristol Myers Squibb discovers, makes and sells prescription medicines for cancer, blood disorders, immune conditions, heart disease and mental health conditions.
Company outlook: revenue of $49B to $50B for Fiscal year 2026 — up 2.7% on a year earlier